Gene · 7296
Papers4,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 4,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune Modulating Brevetoxins: Monocyte Cytotoxicity, Apoptosis, and Activation of M1/M2 Response Elements Is Dependent on Reactive Groups. | Mar Drugs | 2022 | 35447906 | PubTator, text mining | PubMed |
| COPD lung studies of Nrf2 expression and the effects of Nrf2 activators. | Inflammopharmacology | 2022 | 35441963 | PubTator, text mining | PubMed |
| Modulation of Reactive Oxygen Species to Overcome 5-Fluorouracil Resistance. | Biomol Ther (Seoul) | 2022 | 35440517 | PubTator, text mining | PubMed |
| Seven ferroptosis-specific expressed genes are considered as potential biomarkers for the diagnosis and treatment of cigarette smoke-induced chronic obstructive pulmonary disease. | Ann Transl Med | 2022 | 35433978 | PubTator, text mining | PubMed |
| The Selenium Yeast vs Selenium Methionine on Cell Viability, Selenoprotein Profile and Redox Status via JNK/ P38 Pathway in Porcine Mammary Epithelial Cells. | Front Vet Sci | 2022 | 35433920 | PubTator, text mining | PubMed |
| Macrophage Subsets and Death Are Responsible for Atherosclerotic Plaque Formation. | Front Immunol | 2022 | 35432323 | PubTator, text mining | PubMed |
| The role of bile acids in carcinogenesis. | Cell Mol Life Sci | 2022 | 35429253 | PubTator, text mining | PubMed |
| Proteomes of primary skin fibroblasts from healthy individuals reveal altered cell responses across the life span. | Aging Cell | 2022 | 35429111 | PubTator, text mining | PubMed |
| Schisandrin B Induced ROS-Mediated Autophagy and Th1/Th2 Imbalance via Selenoproteins in Hepa1-6 Cells. | Front Immunol | 2022 | 35419003 | PubTator, text mining | PubMed |
| Essential Protective Role of Catalytically Active Antibodies (Abzymes) with Redox Antioxidant Functions in Animals and Humans. | Int J Mol Sci | 2022 | 35409256 | PubTator, text mining | PubMed |
| Comparative Proteomic Profiling of Ectosomes Derived from Thyroid Carcinoma and Normal Thyroid Cells Uncovers Multiple Proteins with Functional Implications in Cancer. | Cells | 2022 | 35406748 | PubTator, text mining | PubMed |
| Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation. | Cancers (Basel) | 2022 | 35406596 | PubTator, text mining | PubMed |
| Oxidative Stress in Intervertebral Disc Degeneration: New Insights from Bioinformatic Strategies. | Oxid Med Cell Longev | 2022 | 35401932 | PubTator, text mining | PubMed |
| PDI inhibitor LTI6426 enhances panobinostat efficacy in preclinical models of multiple myeloma. | Cancer Chemother Pharmacol | 2022 | 35381875 | PubTator, text mining | PubMed |
| Comparative Proteomics Analysis Reveals the Reversal Effect of Cryptotanshinone on Gefitinib-Resistant Cells in Epidermal Growth Factor Receptor-Mutant Lung Cancer. | Front Pharmacol | 2022 | 35370706 | PubTator, text mining | PubMed |
| Dietary Phytochemicals Targeting Nrf2 to Enhance the Radiosensitivity of Cancer. | Oxid Med Cell Longev | 2022 | 35368867 | PubTator, text mining | PubMed |
| Cyclic 5-membered disulfides are not selective substrates of thioredoxin reductase, but are opened nonspecifically. | Nat Commun | 2022 | 35365603 | PubTator, text mining | PubMed |
| Transsulfuration, minor player or crucial for cysteine homeostasis in cancer. | Trends Cell Biol | 2022 | 35365367 | PubTator, text mining | PubMed |
| Knockdown of AKR1C3 Promoted Sorafenib Sensitivity Through Inhibiting the Phosphorylation of AKT in Hepatocellular Carcinoma. | Front Oncol | 2022 | 35359392 | PubTator, text mining | PubMed |
| Redox proteome analysis of auranofin exposed ovarian cancer cells (A2780). | Redox Biol | 2022 | 35358852 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7296/papers?page=59